Journal article

Oral Treatment with Cu-II(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Blaine R Roberts, Nastasia KH Lim, Erin J McAllum, Paul S Donnelly, Dominic J Hare, Philip A Doble, Bradley J Turner, Katherine A Price, Sin Chun Lim, Brett M Paterson, James L Hickey, Timothy W Rhoads, Jared R Williams, Katja M Kanninen, Lin W Hung, Jeffrey R Liddell, Alexandra Grubman, Jean-Francois Monty, Roxana M Llanos, David R Kramer Show all



Awarded by Australian National Health and Medical Research Council

Funding Acknowledgements

This work was supported by funds from the Australian National Health and Medical Research Council (Project Grants 1005651 and 1061550); the Motor Neuron Disease Research Institute of Australia; the Victorian Government Operational Infrastructure Support Program; Bethlehem Griffiths Research Foundation; the CASS Foundation; the Australian Research Council; the National Academy of Finland; the Sigrid Juselius Foundation; and The University of Melbourne.